Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment Novo discontinued last October. Novo Nordisk has handed over STEM-PD, an experimental stem-cell therapy for Parkinson’s disease, to Cellular Intelligence, an AI biotech […]<br /> This story continues at The Next Web [...]
Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The mov [...]
Behold Mark Zuckerberg: man of principle. Witness the Meta CEO's dedication to the most high-minded of causes: "currying favor with whoever's in charge." In 2013, when Barack Obama [...]
On Thursday, The New York Times published a lengthy story about the rise in power of Stephen Miller, a longtime loyalist of Donald Trump known for his hardline views on immigration. Normally, a story [...]